环姜黄素能有效抑制人芳香化酶,是一种潜在的治疗药物。

IF 2.7 2区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
Han Lu, Jingyi Zheng, Chunnan Hu, Jiayi He, Shaowei Wang, Zhuoqi Chen, Yiyan Wang, Huitao Li, Ren-Shan Ge, Yunbing Tang, Yingfen Ying
{"title":"环姜黄素能有效抑制人芳香化酶,是一种潜在的治疗药物。","authors":"Han Lu, Jingyi Zheng, Chunnan Hu, Jiayi He, Shaowei Wang, Zhuoqi Chen, Yiyan Wang, Huitao Li, Ren-Shan Ge, Yunbing Tang, Yingfen Ying","doi":"10.1016/j.jsbmb.2024.106672","DOIUrl":null,"url":null,"abstract":"<p><p>Curcuminoids, including curcumin and its derivatives, show potent inhibition of aromatase (CYP19A1), crucial for estradiol synthesis and breast cancer metastasis. Our study evaluated the efficacy and mechanism of 10 curcuminoids and their metabolites against human and rat CYP19A1 using placental microsomes, revealing species-specific IC<sub>50</sub> values. Cyclocurcumin (IC<sub>50</sub>, 4.43 μM) and curcumin (IC<sub>50</sub>, 3.49 μM) were the most effective inhibitors for human and rat CYP19A1, respectively. These compounds acted as mixed or competitive inhibitors, reducing estradiol production in human BeWo cells. Docking analysis showed that curcuminoids interact with CYP19A1 active site, forming a hydrogen bond with Met374. 3D-QSAR analysis highlighted the importance of hydrogen bonding in inhibition. A negative correlation was observed between the pKa values and IC<sub>50</sub> values for human CYP19A1. A positive correlation was observed between the lowest binding energy and IC<sub>50</sub> values for human CYP19A1. These findings underscore the potential of curcuminoids as therapeutic agents against breast cancer.</p>","PeriodicalId":51106,"journal":{"name":"Journal of Steroid Biochemistry and Molecular Biology","volume":" ","pages":"106672"},"PeriodicalIF":2.7000,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cyclocurcumin potently inhibits human aromatase as a potential therapeutic agent.\",\"authors\":\"Han Lu, Jingyi Zheng, Chunnan Hu, Jiayi He, Shaowei Wang, Zhuoqi Chen, Yiyan Wang, Huitao Li, Ren-Shan Ge, Yunbing Tang, Yingfen Ying\",\"doi\":\"10.1016/j.jsbmb.2024.106672\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Curcuminoids, including curcumin and its derivatives, show potent inhibition of aromatase (CYP19A1), crucial for estradiol synthesis and breast cancer metastasis. Our study evaluated the efficacy and mechanism of 10 curcuminoids and their metabolites against human and rat CYP19A1 using placental microsomes, revealing species-specific IC<sub>50</sub> values. Cyclocurcumin (IC<sub>50</sub>, 4.43 μM) and curcumin (IC<sub>50</sub>, 3.49 μM) were the most effective inhibitors for human and rat CYP19A1, respectively. These compounds acted as mixed or competitive inhibitors, reducing estradiol production in human BeWo cells. Docking analysis showed that curcuminoids interact with CYP19A1 active site, forming a hydrogen bond with Met374. 3D-QSAR analysis highlighted the importance of hydrogen bonding in inhibition. A negative correlation was observed between the pKa values and IC<sub>50</sub> values for human CYP19A1. A positive correlation was observed between the lowest binding energy and IC<sub>50</sub> values for human CYP19A1. These findings underscore the potential of curcuminoids as therapeutic agents against breast cancer.</p>\",\"PeriodicalId\":51106,\"journal\":{\"name\":\"Journal of Steroid Biochemistry and Molecular Biology\",\"volume\":\" \",\"pages\":\"106672\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Steroid Biochemistry and Molecular Biology\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jsbmb.2024.106672\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Steroid Biochemistry and Molecular Biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.jsbmb.2024.106672","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

姜黄素,包括姜黄素及其衍生物,显示出对芳香化酶(CYP19A1)的有效抑制,该酶对雌二醇合成和乳腺癌转移至关重要。本研究利用胎盘微粒体评估了10种姜黄素及其代谢物对人和大鼠CYP19A1的抑制作用和机制,揭示了物种特异性的IC50值。环姜黄素(IC50, 4.43μM)和姜黄素(IC50, 3.49μM)分别是人CYP19A1和大鼠CYP19A1最有效的抑制剂。这些化合物作为混合或竞争性抑制剂,减少人BeWo细胞中雌二醇的产生。对接分析显示姜黄素与CYP19A1活性位点相互作用,与Met374形成氢键。3D-QSAR分析强调了氢键在抑制中的重要性。人类CYP19A1的pKa值与IC50值呈负相关。人类CYP19A1的最低结合能与IC50值呈正相关。这些发现强调了姜黄素作为乳腺癌治疗剂的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cyclocurcumin potently inhibits human aromatase as a potential therapeutic agent.

Curcuminoids, including curcumin and its derivatives, show potent inhibition of aromatase (CYP19A1), crucial for estradiol synthesis and breast cancer metastasis. Our study evaluated the efficacy and mechanism of 10 curcuminoids and their metabolites against human and rat CYP19A1 using placental microsomes, revealing species-specific IC50 values. Cyclocurcumin (IC50, 4.43 μM) and curcumin (IC50, 3.49 μM) were the most effective inhibitors for human and rat CYP19A1, respectively. These compounds acted as mixed or competitive inhibitors, reducing estradiol production in human BeWo cells. Docking analysis showed that curcuminoids interact with CYP19A1 active site, forming a hydrogen bond with Met374. 3D-QSAR analysis highlighted the importance of hydrogen bonding in inhibition. A negative correlation was observed between the pKa values and IC50 values for human CYP19A1. A positive correlation was observed between the lowest binding energy and IC50 values for human CYP19A1. These findings underscore the potential of curcuminoids as therapeutic agents against breast cancer.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
8.60
自引率
2.40%
发文量
113
审稿时长
46 days
期刊介绍: The Journal of Steroid Biochemistry and Molecular Biology is devoted to new experimental and theoretical developments in areas related to steroids including vitamin D, lipids and their metabolomics. The Journal publishes a variety of contributions, including original articles, general and focused reviews, and rapid communications (brief articles of particular interest and clear novelty). Selected cutting-edge topics will be addressed in Special Issues managed by Guest Editors. Special Issues will contain both commissioned reviews and original research papers to provide comprehensive coverage of specific topics, and all submissions will undergo rigorous peer-review prior to publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信